Cancer Epidemiology Biomarkers & Prevention, Vol 2, Issue 4 381-387, Copyright © 1993 by American Association for Cancer Research

ARTICLES

The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with asbestos-exposed workers

GS Omenn, GE Goodman, MD Thornquist, L Rosenstock, S Barnhart, I Gylys-Colwell, B Metch and B Lund
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.

Pilot studies are an essential component for major chemoprevention trials. Prior to initiating the multicenter Carotene and Retinol Efficacy Trial to assess the effectiveness of beta-carotene and retinol for preventing lung cancer, we conducted pilot studies in Seattle between 1985 and 1988 in two high risk populations: current and former heavy smokers and asbestos-exposed workers. The Asbestos Workers Pilot Study for the Carotene and Retinol Efficacy Trial demonstrated that recruitment of asbestos-exposed participants with relevant risk factors was feasible from identified sources. We documented negligible toxicity and high adherence with the protocol, schedule, and intervention. Results from the pilot led to extension of the placebo run-in period, changes in the eligibility criteria, improvements in recruitment strategies and scheduling, elimination of stratification by risk factors in randomization, modifications of study vitamin dosage and of side effects monitoring, and refinement of trial design parameters for Carotene and Retinol Efficacy Trial. The Smokers Pilot is reported in the accompanying article (G. E. Goodman et al., Cancer Epidemiol., Biomarkers & Prev., 2: 389-396, 1993).

This article has been cited by other articles:

				L. B. Michaud, J. P. Karpinski, K. L. Jones, and J. Espirito Dietary supplements in patients with cancer: Risks and key concepts, part 1 Am. J. Health Syst. Pharm., February 15, 2007; 64(4): 369 - 381. [Abstract] [Full Text] [PDF]

				G. E. Goodman, M. D. Thornquist, J. Balmes, M. R. Cullen, F. L. Meyskens Jr., G. S. Omenn, B. Valanis, and J. H. Williams Jr. The Beta-Carotene and Retinol Efficacy Trial: Incidence of Lung Cancer and Cardiovascular Disease Mortality During 6-Year Follow-up After Stopping {beta}-Carotene and Retinol Supplements J Natl Cancer Inst, December 1, 2004; 96(23): 1743 - 1750. [Abstract] [Full Text] [PDF]

				M. L. Neuhouser, R. E. Patterson, M. D. Thornquist, G. S. Omenn, I. B. King, and G. E. Goodman Fruits and Vegetables Are Associated with Lower Lung Cancer Risk Only in the Placebo Arm of the {beta}-Carotene and Retinol Efficacy Trial (CARET) Cancer Epidemiol. Biomarkers Prev., April 1, 2003; 12(4): 350 - 358. [Abstract] [Full Text] [PDF]

				C. Ballew, B. A Bowman, R. M Russell, A. L Sowell, and C. Gillespie Serum retinyl esters are not associated with biochemical markers of liver dysfunction in adult participants in the third National Health and Nutrition Examination Survey (NHANES III), 1988-1994 Am. J. Clinical Nutrition, May 1, 2001; 73(5): 934 - 940. [Abstract] [Full Text] [PDF]

				B. Cartmel, T. E Moon, and N. Levine Effects of long-term intake of retinol on selected clinical and laboratory indexes Am. J. Clinical Nutrition, May 1, 1999; 69(5): 937 - 943. [Abstract] [Full Text] [PDF]

				G. S. Omenn, G. E. Goodman, M. D. Thornquist, J. Balmes, M. R. Cullen, A. Glass, J. P. Keogh, F. L. Meyskens, B. Valanis, J. H. Williams, et al. Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular Disease N. Engl. J. Med., May 2, 1996; 334(18): 1150 - 1155. [Abstract] [Full Text] [PDF]